These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 37128293)

  • 1. Adipose tissue metabolic changes in chronic kidney disease.
    Serrano E; Shenoy P; Martinez Cantarin MP
    Immunometabolism (Cobham); 2023 Apr; 5(2):e00023. PubMed ID: 37128293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of adipose tissue in chronic kidney disease development (Review).
    Miricescu D; Balan DG; Tulin A; Stiru O; Vacaroiu IA; Mihai DA; Popa CC; Enyedi M; Nedelea AS; Nica AE; Stefani C
    Exp Ther Med; 2021 May; 21(5):539. PubMed ID: 33815612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk.
    Wu J; Dong J; Verzola D; Hruska K; Garibotto G; Hu Z; Mitch WE; Thomas SS
    J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1210-1227. PubMed ID: 31507080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin as an uremic toxin: Deleterious role of leptin in chronic kidney disease.
    Alix PM; Guebre-Egziabher F; Soulage CO
    Biochimie; 2014 Oct; 105():12-21. PubMed ID: 25010649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perirenal Adipose Tissue Inflammation: Novel Insights Linking Metabolic Dysfunction to Renal Diseases.
    Hammoud SH; AlZaim I; Al-Dhaheri Y; Eid AH; El-Yazbi AF
    Front Endocrinol (Lausanne); 2021; 12():707126. PubMed ID: 34408726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the Crosstalk Between Adipose Tissue and Mineral Balance in General Population and Chronic Kidney Disease.
    Karava V; Christoforidis A; Kondou A; Dotis J; Printza N
    Front Pediatr; 2021; 9():696942. PubMed ID: 34422722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue: between the extremes.
    Vegiopoulos A; Rohm M; Herzig S
    EMBO J; 2017 Jul; 36(14):1999-2017. PubMed ID: 28623240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade.
    de Vinuesa SG; Goicoechea M; Kanter J; Puerta M; Cachofeiro V; Lahera V; Gómez-Campderá F; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S206-12. PubMed ID: 17130263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of natriuretic peptides is associated with protein energy wasting and activation of browning in white adipose tissue in chronic kidney disease.
    Luce M; Barba C; Yi D; Mey A; Roussel D; Bres E; Benoit B; Pastural M; Granjon S; Szelag JC; Laville M; Arkouche W; Bouchara A; Nyam E; Fouque D; Soulage CO; Koppe L
    Kidney Int; 2020 Sep; 98(3):663-672. PubMed ID: 32739210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity-related kidney disease: Beyond hypertension and insulin-resistance.
    Arabi T; Shafqat A; Sabbah BN; Fawzy NA; Shah H; Abdulkader H; Razak A; Sabbah AN; Arabi Z
    Front Endocrinol (Lausanne); 2022; 13():1095211. PubMed ID: 36726470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer.
    Rajesh Y; Sarkar D
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome - dysregulation of adipose tissue endocrine function.
    Horská K; Kučerová J; Suchý P; Kotolová H
    Ceska Slov Farm; 2014 Aug; 63(4):152-9. PubMed ID: 25246153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feeding the critically ill obese patient: a systematic review protocol.
    Secombe P; Harley S; Chapman M; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):95-109. PubMed ID: 26571286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine functions of adipose tissue.
    Waki H; Tontonoz P
    Annu Rev Pathol; 2007; 2():31-56. PubMed ID: 18039092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth Hormone Improves Adipose Tissue Browning and Muscle Wasting in Mice with Chronic Kidney Disease-Associated Cachexia.
    Mak RH; Gunta S; Oliveira EA; Cheung WW
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD.
    Navaneethan SD; Kirwan JP; Remer EM; Schneider E; Addeman B; Arrigain S; Horwitz E; Fink JC; Lash JP; McKenzie CA; Rahman M; Rao PS; Schold JD; Shafi T; Taliercio JJ; Townsend RR; Feldman HI;
    Am J Kidney Dis; 2021 Jan; 77(1):44-55. PubMed ID: 32798563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energy homeostasis and cachexia in chronic kidney disease.
    Mak RH; Cheung W
    Pediatr Nephrol; 2006 Dec; 21(12):1807-14. PubMed ID: 16897005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipokines mediate inflammation and insulin resistance.
    Kwon H; Pessin JE
    Front Endocrinol (Lausanne); 2013; 4():71. PubMed ID: 23781214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia.
    Weber BZC; Arabaci DH; Kir S
    Front Oncol; 2022; 12():848394. PubMed ID: 35646636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on metabolic syndrome: Metabolic risk markers and adipokines in the development of metabolic syndrome.
    Kumari R; Kumar S; Kant R
    Diabetes Metab Syndr; 2019; 13(4):2409-2417. PubMed ID: 31405652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.